Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cholangiocarcinoma.

S A Ahrendt1, A Nakeeb, H A Pitt

  • 1Department of Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Clinics in Liver Disease
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Opioid analgesia in necrotizing pancreatitis: Incidence and timing of a hidden crisis.

American journal of surgery·2023
Same author

Operative treatment of portal vein aneurysm.

Surgery open science·2022
Same author

Routine Gastric Decompression after Pancreatoduodenectomy: Treating the Surgeon?

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2021
Same author

Necrotizing Pancreatitis from Hypertriglyceridemia: More Severe Disease?

Digestive diseases and sciences·2021
Same author

Hepatic Steatosis After Neoadjuvant Chemotherapy for Pancreatic Cancer: Incidence and Implications for Outcomes After Pancreatoduodenectomy.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2020
Same author

Discussion on: Two open whipples a day: Excessive or efficient.

American journal of surgery·2020
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles

Early diagnosis and improved staging are crucial for enhancing cholangiocarcinoma survival. Advances in molecular screening and noninvasive imaging techniques offer hope for better patient outcomes in this challenging biliary tract cancer.

Area of Science:

  • Oncology
  • Gastroenterology
  • Medical Imaging

Background:

  • Cholangiocarcinoma (bile duct cancer) has a poor prognosis despite diagnostic and treatment advances.
  • Early detection and improved staging are critical for enhancing patient survival rates.

Purpose of the Study:

  • To review current and emerging strategies for improving the diagnosis, staging, and treatment of cholangiocarcinoma.
  • To highlight the need for further research in adjuvant therapies and palliative care.

Main Methods:

  • Review of current diagnostic modalities including molecular screening and advanced imaging (CT, MRI, PET).
  • Discussion of surgical resection as the primary curative treatment.
  • Exploration of challenges in managing jaundiced and septic patients undergoing surgery.

Related Experiment Videos

  • Consideration of palliative care options for unresectable disease.

    • Main Results:

    • Early diagnosis via molecular screening in high-risk groups (e.g., primary sclerosing cholangitis) is essential.
    • Advanced imaging techniques improve noninvasive staging of cholangiocarcinoma.
    • Complete surgical resection remains the only curative option, though challenging in complex cases.
    • Optimal palliative strategies for unresectable cholangiocarcinoma require further definition.

    Conclusions:

    • Improving cholangiocarcinoma prognosis hinges on earlier diagnosis and more precise staging.
    • Multicenter trials are needed to establish effective chemoradiation as adjuvant therapy.
    • Further research into surgical safety, palliative care, and adjuvant treatments is imperative.